Compare LYTS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYTS | CADL |
|---|---|---|
| Founded | 1976 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 698.9M | 578.8M |
| IPO Year | 1994 | 2021 |
| Metric | LYTS | CADL |
|---|---|---|
| Price | $23.07 | $8.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $27.50 | $19.00 |
| AVG Volume (30 Days) | 490.9K | ★ 2.1M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.87% | N/A |
| EPS Growth | N/A | ★ 58.62 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $573,377,000.00 | $125,000.00 |
| Revenue This Year | $16.20 | N/A |
| Revenue Next Year | $27.71 | N/A |
| P/E Ratio | $46.94 | ★ N/A |
| Revenue Growth | ★ 22.09 | N/A |
| 52 Week Low | $15.62 | $4.35 |
| 52 Week High | $24.99 | $9.27 |
| Indicator | LYTS | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 58.29 |
| Support Level | $21.76 | $4.91 |
| Resistance Level | $23.84 | $9.27 |
| Average True Range (ATR) | 0.76 | 0.65 |
| MACD | -0.28 | -0.12 |
| Stochastic Oscillator | 37.79 | 30.53 |
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.